COPD: new lessons from alpha1-antitrypsin deficiency?
Wanner
Adam
A
University of Miami Miller School of Medicine, Miami, FL. Electronic address: awanner@miami.edu.
D015897:Comorbidity; D020022:Genetic Predisposition to Disease; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology*; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use; D012907:Smoking / Q000453:epidemiology / Q000503:physiopathology; D000515:alpha 1-Antitrypsin / Q000627:therapeutic use; D019896:alpha 1-Antitrypsin Deficiency / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology*
D015842:Serine Proteinase Inhibitors; D000515:alpha 1-Antitrypsin